Literature DB >> 12511672

Preoperative depiction of hepatocellular carcinoma: ferumoxides-enhanced MR imaging versus triple-phase helical CT.

Bo Kiung Kang1, Jae Hoon Lim, Seung Hoon Kim, Dongil Choi, Hyo Keun Lim, Won Jae Lee, Soon Jin Lee.   

Abstract

PURPOSE: To compare ferumoxides-enhanced magnetic resonance (MR) imaging with triple-phase helical computed tomography (CT) for the preoperative depiction of hepatocellular carcinoma (HCC).
MATERIALS AND METHODS: Seventy consecutive patients with a total of 79 HCC nodules underwent ferumoxides-enhanced MR imaging and triple-phase helical CT before surgery. The diagnosis of HCC was established by means of pathologic examination after surgical resection in all patients. MR images obtained with all sequences and triple-phase helical CT images were reviewed independently by three radiologists on a segment-by-segment basis. Accuracy for diagnosis of HCC was assessed by applying receiver operating characteristic (ROC) analysis to observations of 78 hepatic segments with at least one HCC nodule and 70 segments without HCC.
RESULTS: The diagnostic accuracy of findings at ferumoxides-enhanced MR imaging (with mean area-under-the-ROC-curve [A(z)] values for the three observers of 0.986, 0.979, and 0.980) was significantly higher (P <.001) than that of findings at triple-phase helical CT (with mean A(z) values for the three observers of 0.945, 0.948, and 0.964). The mean sensitivity of MR imaging (95%, 222 of 234 segments) was also significantly higher than that of triple-phase helical CT (88%, 205 of 234 segments) (P =.001, McNemar test). The mean specificity was 97% (261 of 270 segments) for MR imaging and 98% (264 of 270 segments) for CT, but this difference was not significant (P =.754, McNemar test).
CONCLUSION: Ferumoxides-enhanced MR imaging is superior to triple-phase helical CT for the preoperative depiction of HCC. Copyright RSNA, 2003

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12511672     DOI: 10.1148/radiol.2261011827

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  15 in total

1.  Small (≤ 2 cm) hepatocellular carcinoma in patients with chronic liver disease: comparison of gadoxetic acid-enhanced 3.0 T MRI and multiphasic 64-multirow detector CT.

Authors:  J Hwang; S H Kim; M W Lee; J Y Lee
Journal:  Br J Radiol       Date:  2011-12-13       Impact factor: 3.039

Review 2.  What is the current situation in liver imaging?

Authors:  M M Uggowitzer
Journal:  Eur Radiol       Date:  2003-11       Impact factor: 5.315

3.  Atypical hemangioma mimicking hepatocellular carcinoma with a special note on radiological and pathological findings.

Authors:  Masakatsu Tsurusaki; Ryota Kawasaki; Masato Yamaguchi; Koji Sugimoto; Takumi Fukumoto; Yonson Ku; Kazuro Sugimura
Journal:  Jpn J Radiol       Date:  2009-05-03       Impact factor: 2.374

4.  Clinical management of hepatic malignancies: ferucarbotran-enhanced magnetic resonance imaging versus contrast-enhanced spiral computed tomography.

Authors:  Riccardo Lencioni; Clotilde Della Pina; Jordi Bruix; Pietro Majno; Luigi Grazioli; Giovanni Morana; Antonella Filippone; Andrea Laghi; Carlo Bartolozzi
Journal:  Dig Dis Sci       Date:  2005-03       Impact factor: 3.199

5.  Performance of radiological methods in diagnosing hepatocellular carcinoma preoperatively in a recipient of living related liver transplantation: comparison with step section histopathology.

Authors:  Masakazu Hirakawa; Kengo Yoshimitsu; Hiroyuki Irie; Tsuyoshi Tajima; Akihiro Nishie; Yoshiki Asayama; Kousei Ishigami; Daisuke Kakihara; Akinobu Taketomi; Shin-ichi Aishima; Hiroshi Honda
Journal:  Jpn J Radiol       Date:  2011-02-27       Impact factor: 2.374

6.  A case of atypical caudate lobe hemangioma mimicking hepatocellular carcinoma: CT and angiographic manifestations.

Authors:  Hsin-Chi Chen; Chi-Ming Lee; Ching-Shyang Chen; Chih-Hsiung Wu
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

7.  MR characterisation of dysplastic nodules and hepatocarcinoma in the cirrhotic liver with hepatospecific superparamagnetic contrast agents: pathological correlation in explanted livers.

Authors:  L Macarini; P Milillo; A Cascavilla; G Scalzo; L Stoppino; R Vinci; G Moretti; G Ettorre
Journal:  Radiol Med       Date:  2009-11-09       Impact factor: 3.469

8.  Detection of hepatocellular carcinoma: comparison of ferumoxides-enhanced and gadolinium-enhanced dynamic three-dimensional volume interpolated breath-hold MR imaging.

Authors:  Hyo-Sung Kwak; Jeong-Min Lee; Young-Kon Kim; Young Hwan Lee; Chong-Soo Kim
Journal:  Eur Radiol       Date:  2004-09-22       Impact factor: 5.315

9.  Gadoxetic acid (Gd-EOB-DTPA)-enhanced MRI versus gadobenate dimeglumine (Gd-BOPTA)-enhanced MRI for preoperatively detecting hepatocellular carcinoma: an initial experience.

Authors:  Yulri Park; Seong Hyun Kim; Seung Hoon Kim; Yong Hwan Jeon; Jongmee Lee; Min Ju Kim; Dongil Choi; Won Jae Lee; Heejung Kim; Ji Hyun Koo; Hyo Keun Lim
Journal:  Korean J Radiol       Date:  2010-06-21       Impact factor: 3.500

10.  SPIO-enhanced MRI findings of well-differentiated hepatocellular carcinomas: correlation with MDCT findings.

Authors:  Seong Hyun Kim; Won Jae Lee; Hyo K Lim; Cheol Keun Park
Journal:  Korean J Radiol       Date:  2009-03-03       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.